Biallelic truncation variants in ATP9A are associated with a novel autosomal recessive neurodevelopmental disorder.
Francesca MattioliHossein DarvishSohail Aziz ParachaAbbas TafakhoriSaghar Ghasemi FirouzabadiMarjan ChapiHafiz Muhammad Azhar BaigAlexandre ReymondStylianos E AntonarakisMuhammad AnsarPublished in: NPJ genomic medicine (2021)
Intellectual disability (ID) is a highly heterogeneous disorder with hundreds of associated genes. Despite progress in the identification of the genetic causes of ID following the introduction of high-throughput sequencing, about half of affected individuals still remain without a molecular diagnosis. Consanguineous families with affected individuals provide a unique opportunity to identify novel recessive causative genes. In this report, we describe a novel autosomal recessive neurodevelopmental disorder. We identified two consanguineous families with homozygous variants predicted to alter the splicing of ATP9A which encodes a transmembrane lipid flippase of the class II P4-ATPases. The three individuals homozygous for these putatively truncating variants presented with severe ID, motor and speech impairment, and behavioral anomalies. Consistent with a causative role of ATP9A in these patients, a previously described Atp9a-/- mouse model showed behavioral changes.
Keyphrases
- intellectual disability
- copy number
- autism spectrum disorder
- genome wide
- mouse model
- end stage renal disease
- bioinformatics analysis
- high throughput sequencing
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- early onset
- congenital heart disease
- patient reported outcomes
- genome wide identification
- single molecule
- patient reported